The potential of acetylsalicylic acid and vitamin E in modulating inflammatory cascades in chickens under lipopolysaccharide-induced inflammation

International audienceAbstractDistinct enzymes, including cyclooxygenase 1 and 2 (COX-1 and COX-2), lipoxygenase (LOXs), and cytochrome P450 monooxygenase (CYP450), produce different stress mediators and mediate inflammation in birds. Bioactive agents such as acetylsalicylic acid (ASA) and vitamin E (vE) may affect enzyme activities and could be used in poultry production to control the magnitude of acute phase inflammation. Here, we characterized COX, LOX, and CYP450 mRNA expression levels in chicken immune tissues in response to Escherichia coli lipopolysaccharide (LPS) challenge and investigated whether ASA and vE could alter gene expression. Additionally, for the first time in chickens, we evaluated oxygen consumption by platelet mitochondria as a biomarker of mitochondria function in response to ASA- and vE. LPS challenge compromised bird growth rates, but neither dietary ASA nor vE significantly ameliorated this effect; however, gradually increasing dietary vE levels were more effective than basal levels. ASA regulated arachidonic acid metabolism, providing an eicosanoid synthesis substrate, whereas gradually increasing vE levels evoked aspirin resistance during challenge. Gene expression in immune tissues was highly variable, indicating a complex regulatory network controlling inflammatory pathways. However, unlike COX-1, COX-2 and CYP450 exhibited increased mRNA expression in some cases, suggesting an initiation of novel anti-inflammatory and pro-resolving signals during challenge. Measuring oxygen consumption rate, we revealed that neither the ASA nor vE levels applied here exerted toxic effects on platelet mitochondria

Progress on Cleaning Up the Only Commercial Nuclear Fuel Reprocessing Facility to Operate in the United States

This paper describes the progress on cleanup of the West Valley Demonstration Project (WVDP), an environmental management project located south of Buffalo, NY. The WVDP was the site of the only commercial nuclear fuel reprocessing facility to have operated in the United States (1966 to 1972). Former fuel reprocessing operations generated approximately 600,000 gallons of liquid high-level radioactive waste stored in underground tanks. The U.S. Congress passed the WVDP Act in 1980 (WVDP Act) to authorize cleanup of the 220-acre facility. The facility is unique in that it sits on the 3,345-acre Western New York Nuclear Service Center (WNYNSC), which is owned by New York State through the New York State Energy Research and Development Authority (NYSERDA). The U.S. Department of Energy (DOE) has overall responsibility for the cleanup that is authorized by the WVDP Act, paying 90 percent of the WVDP costs; NYSERDA pays 10 percent. West Valley Nuclear Services Company (WVNSCO) is the management contractor at the WVDP. This paper will provide a description of the many accomplishments at the WVDP, including the pretreatment and near completion of vitrification of all the site's liquid high-level radioactive waste, a demonstration of technologies to characterize the remaining material in the high-level waste tanks, the commencement of decontamination and decommissioning (D&D) activities to place the site in a safe configuration for long-term site management options, and achievement of several technological firsts. It will also include a discussion of the complexities involved in completing the WVDP due to the various agency interests that require integration for future cleanup decisions

Lipidomic Profile and Enzymes Activity in Hepatic Microsomes of Rats in Physiological and Pathological Conditions

Among the risk factors affecting the development of cancer, nutritional factors occupy a significant place. Pomegranate seed oil (PSO) and bitter melon extract (BME), used for ages in folk medicine, are nowadays used in the prevention of many diseases and as ingredients of dietary supplements. Despite numerous publications on these raw materials or their active substances, their mechanism of action in various pathological states has not been recognized yet, nor has the safety of their simultaneous use been evaluated. The study aimed to assess how dietary supplementation with either PSO, with BME, or both, affects fatty acids’ profiles and their metabolism in hepatic microsomes, as well as the activity of selected microsomal enzymes (COX-2 and CYP1B1). Experimental animals (Sprague-Dawley rats) were divided into eight parallel experimental groups, differing in applied dietary modifications (control, PSO, BME and both PSO and BME) and introduction of chemical carcinogen—7,12-dimethylbenz[a]nthracene. Obtained results indicated the pronounced effect of the cancerous process on lipid metabolism and demonstrated the antagonistic effect of applied dietary supplements on the content of individual fatty acids and the activity of CYP1B1 and COX-2. The applied broad analytical approach and chemometric data analysis confirmed that raw materials, for which potential cancer prevention has been previously demonstrated, may differ in effects depending on the coexisting pathological state